John Militello, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 6,476 shares at $29.84 ($193K) on 2024-02-16, disclosed to the SEC on 2024-02-21.
Open-market sale of $193k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.84 | 3,238 | $97K | 50.0% |
| 2 | $29.84 | 3,238 | $97K | 50.0% |
| Total | $29.84 avg | 6,476 | $193K | 100% |
| Filing → |
| RCKT | SELL | 2026-02-20 | $4K | — | Filing → |
| RCKT | SELL | 2026-02-18 | $12K | — | Filing → |
| RCKT | SELL | 2025-11-20 | $3K | — | Filing → |